It is also important to note that decreased fluid intake and fluid loss that might result from nausea and vomiting, the main adverse effects of these agents, can further injure the kidneys
They mimic or amplify GLP-1s effects in the body: Reduce hunger and increase fullness Improve insulin response and prevent blood sugar spikes Slow digestion to regulate appetite and glucose Support weight management when paired with lifestyle changes Reduce cardiovascular risks in some patients These medications stay active longer than natural GLP-1, giving consistent support for glucose and appetite control
Early phases of therapy often involve shifts in digestion, hunger cues, and energy patterns
A total of 156 trial participants were randomized to receive daily liraglutide (30 mg) ( n = 80) or placebo ( n = 76) for 52 weeks
Many researchers report feeling slightly warmer, especially during physical activity
Some notice mild nausea during the first 2 to 3 days after the initial injection